Inventor
MATTEUCCI MARK
US44 patents
⚠️ This page may combine multiple inventors who share the name “MATTEUCCI MARK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GILEAD SCIENCES INC
12 patentsUS6005096ADec 21, 1999
Pyrimidine derivatives
GILEAD SCIENCES INC880 citations99
US5817781AOct 6, 1998
Modified internucleoside linkages (II)
GILEAD SCIENCES INC123 citations99
US5792847AAug 11, 1998
2' Modified Oligonucleotides
GILEAD SCIENCES INC529 citations99
US5594121AJan 14, 1997
Enhanced triple-helix and double-helix formation with oligomers containing modified purines
GILEAD SCIENCES INC1,432 citations99
US5264562ANov 23, 1993
Oligonucleotide analogs with novel linkages
GILEAD SCIENCES INC1,181 citations99
US5214136AMay 25, 1993
Anthraquinone-derivatives oligonucleotides
GILEAD SCIENCES INC1,165 citations99
US5830653ANov 3, 1998
Methods of using oligomers containing modified pyrimidines
GILEAD SCIENCES INC1,023 citations98
US5792608AAug 11, 1998
Nuclease stable and binding competent oligomers and methods for their use
GILEAD SCIENCES INC563 citations98
US5672697ASep 30, 1997
Nucleoside 5'-methylene phosphonates
GILEAD SCIENCES INC527 citations98
US5645985AJul 8, 1997
Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines
GILEAD SCIENCES INC968 citations98
US5596086AJan 21, 1997
Modified internucleoside linkages having one nitrogen and two carbon atoms
GILEAD SCIENCES INC1,435 citations98
US5495009AFeb 27, 1996
Oligonucleotide analogs containing thioformacetal linkages
GILEAD SCIENCES INC85 citations95
ISIS PHARMACEUTICALS INC
9 patentsUS6476205B1Nov 5, 2002
2′ Modified oligonucleotides
ISIS PHARMACEUTICALS INC305 citations99
US6875593B2Apr 5, 2005
Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines
ISIS PHARMACEUTICALS INC102 citations98
US6410702B1Jun 25, 2002
Modified internucleoside linkages (II)
ISIS PHARMACEUTICALS INC59 citations96
US6683166B2Jan 27, 2004
Modified internucleoside linkages (ii)
ISIS PHARMACEUTICALS INC5 citations74
US7057027B2Jun 6, 2006
Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines
ISIS PHARMACEUTICALS INC4 citations73
US6962783B2Nov 8, 2005
Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines
ISIS PHARMACEUTICALS INC4 citations73
US6911540B2Jun 28, 2005
2′ Modified oligonucleotides
ISIS PHARMACEUTICALS INC3 citations63
US6967079B2Nov 22, 2005
Pyrimidine derivatives for labeled binding partners
ISIS PHARMACEUTICALS INC0 citations52
US6617437B1Sep 9, 2003
Pyrimidine derivatives for labeled binding partners
ISIS PHARMACEUTICALS INC0 citations46
THRESHOLD PHARMACEUTICALS INC
6 patentsUS6989140B2Jan 24, 2006
Methods for cancer imaging
THRESHOLD PHARMACEUTICALS INC55 citations95
US7001888B2Feb 21, 2006
Compositions and methods for treating cancer
THRESHOLD PHARMACEUTICALS INC40 citations91
US8003625B2Aug 23, 2011
Phosphoramidate alkylator prodrugs
THRESHOLD PHARMACEUTICALS INC12 citations83
US7550496B2Jun 23, 2009
Compositions and methods for treating cancer
THRESHOLD PHARMACEUTICALS INC13 citations82
US9226932B2Jan 5, 2016
Phosphoramidate alkylator prodrugs
THRESHOLD PHARMACEUTICALS INC1 citations62
US8664204B2Mar 4, 2014
Phosphoramidate alkylator prodrugs
THRESHOLD PHARMACEUTICALS INC2 citations62
OBI PHARMA INC
5 patentsUS10409869B2Sep 10, 2019
(R)- and (S)-1-(3-(3-N,N-dimethylaminocarbonyl)phenoxyl-4-nitrophenyl)-1-ethyl-N,N'-bis (ethylene)phosphoramidate, compositions and methods for their use and preparation
OBI PHARMA INC1 citations71
US10364261B2Jul 30, 2019
DNA alkylating agents
OBI PHARMA INC2 citations71
US11535585B2Dec 27, 2022
Nitrobenzyl derivatives of anti-cancer agents
OBI PHARMA INC0 citations60
US10766914B2Sep 8, 2020
DNA alkylating agents
OBI PHARMA INC1 citations60
US10829437B2Nov 10, 2020
Nitrobenzyl derivatives of anti-cancer agents
OBI PHARMA INC0 citations50
GILEAD SCIENCES
3 patentsUS5466786ANov 14, 1995
2'modified nucleoside and nucleotide compounds
GILEAD SCIENCES1,375 citations99
US5414077AMay 9, 1995
Non-nucleoside linkers for convenient attachment of labels to oligonucleotides using standard synthetic methods
GILEAD SCIENCES912 citations99
US5264564ANov 23, 1993
Oligonucleotide analogs with novel linkages
GILEAD SCIENCES1,487 citations99
MOLECULAR TEMPLATES INC
3 patentsUS10654876B2May 19, 2020
TH-302 solid forms and methods related thereto
MOLECULAR TEMPLATES INC0 citations50
US10131683B2Nov 20, 2018
TH-302 solid forms and methods related thereto
MOLECULAR TEMPLATES INC1 citations50
US10668047B2Jun 2, 2020
Aziridine containing DNA alkylating agents
MOLECULAR TEMPLATES INC0 citations39